Login
Request a demo

Category: Uncategorized

Categories
Uncategorized

What can Europeans learn from Canada for the upcoming EU joint HTA, Gabriel Tremblay?

Dive into the future of healthcare collaboration in Europe with an eye-opening discussion on the upcoming EU joint Health Technology Assessment (HTA). With the European Commission’s recent announcement, the healthcare landscape is poised for a significant shift, yet questions linger about its implementation, timing, and integration into national frameworks across EU member states. How will this compare to Canada’s pioneering joint HTA process, established in the early 2000s, which harmonized evaluations across its provinces?

Join Dr. Stefan Walzer and Gabriel Tremblay, a renowned Canadian Health Economic Expert, as they explore the invaluable lessons European healthcare systems can draw from Canada’s experience. This conversation promises to shed light on critical aspects of reimbursement and market access that could shape the future of healthcare in Europe.

Listen to the podcast: here

Categories
Uncategorized

Digital Health Care is already fully utilized in the US, isn’t it?

Step into the future of healthcare with Dr. Stefan Walzer and Kate Claessens, on this podcast episode where we dissect the pulse of digital health in the USA. From public acceptance to intricate reimbursement pathways, and the potential shifts under the Biden administration, we’re covering the essentials you need to know. How does digital healthcare navigate the complex US reimbursement landscape? What strategic moves should you anticipate next?

Join us as we delve into these critical discussions, offering more expert insights with the practical experience of Anna Forsythe, a titan in global product commercialization and strategic drug development from Purple Squirrel Economics. Whether you’re eyeing the US market for your digital health solutions or simply keen on the latest in healthcare innovation, this episode is your roadmap to understanding and conquering one of the world’s most lucrative markets.

Listen to the podcast: here

Categories
Uncategorized

Does the Italian reimbursement pathway allow for innovative drugs being highly priced, Dr. Stefano Capri and Dr. Entela Xoxi?


Venture into the heart of Italy’s healthcare system with Dr. Stefan Walzer and two Italian experts, Prof. Dr. Stefano Capri and Dr. Entela Xoxi, as they unravel the complexities of the Italian reimbursement landscape. This episode takes you behind the scenes of Italy’s innovation pathway, exploring what this evolution means for the pharmaceutical industry and health care accessibility. Is negotiating a premium price for new treatments as straightforward as it seems? Join us for an enlightening discussion that sheds light on these questions and more. Don’t miss out on the opportunity to deepen your understanding of global market access strategies. Subscribe now on your favorite podcast platform or listen directly on our website. Stay ahead of the curve with MArS, your go-to bi-weekly podcast for exclusive insights into market access and pricing strategies.

Listen to the podcast: here

Categories
Uncategorized

How do innovations reach patients in German hospitals, Dr. Sebastian Casu?

Unlock the secrets to healthcare innovation in this podcast episode as Dr. Stefan Walzer and Dr. Sebastian Casu, a renowned medical doctor and influencer, delve into the pivotal role of NUBs, OPS, and DRG values in patient care. Wondering how groundbreaking innovations bypass administrative hurdles to reach those in need? Or what the future holds for digital health care in Germany? Our experts continue the riveting discussion from Episode 9, featuring insights from Willi Wöllner, to explore the cutting-edge of inpatient market access and digital healthcare advancements. Don’t let this conversation pass you by – tune in now for a deep dive into bedside innovation and the digital transformation of healthcare. Be part of the forefront of market access dialogue with MArS, the first and only bi-weekly podcast dedicated to market access insights.

Listen to the podcast: here

Categories
Uncategorized

How does hospital funding work in Germany, Willi Wöllner?

Dive into the intricate world of reimbursement within the German hospital setting with Dr. Stefan Walzer and experienced hospital administrator Willi Wöllner as they unravel the complexities of inpatient care negotiations. Ever wondered how hospitals and health insurance funds hash out annual budgets? Or what a NUB is and its significance in these discussions? Perhaps you’re curious if industry really can take part in this process. Our experts are peeling back the layers of the business side of hospital operations, setting the stage for an enlightening follow-up on the medical perspective with Dr. Sebastian Casu in the next episode. Don’t miss this insightful journey into the heart of healthcare financing. Subscribe now on your favorite podcast platform and connect with the cutting-edge insights from MArS Market Access and Pricing Strategy.

Listen to the podcast: here

Categories
Uncategorized

Bibiane Schulte-Bosse – How to fight well in AMNOG negotiations.

Step into the high-stakes world of healthcare negotiations in this podcast episode, where Dr. Stefan Walzer, together with negotiation expert and lawyer Bibiane Schulte-Bosse, unravels the intricate dance of price negotiations within the AMNOG process. This episode offers a deep dive into the critical negotiation phase of AMNOG, shedding light on strategies and insights that define the outcome of healthcare product market access in Germany. Curious about the behind-the-scenes of healthcare negotiations? Have questions you’re burning to ask? Join us for a riveting exploration of the AMNOG negotiations. Subscribe on your favorite podcasting platform to never miss an insight!

Listen to the podcast: here

Categories
Uncategorized

Prof. Dr. David Matusiewicz & Dr. Anne Sophie Geier – 1 year DIGAs.

Join Dr. Stefan Walzer as he delves into the transformative world of digital health with a critical look at the first year of DIGAs. Is the “fast track process” for digital health applications truly making waves in healthcare innovation? This episode brings in the expertise of two digital health luminaries, Prof. Dr. David Matusiewicz of FOM University and Dr. Anne Sophie Geier from the head association of digital healthcare SVDGV, to dissect the current state of digitalization in the German healthcare system. Engage with the forefront of digital healthcare discussions and stay ahead of the curve. Don’t miss out on this opportunity to connect with the digital pulse of healthcare. Subscribe to our podcast on your favorite platform and be part of the conversation shaping the future of health.

Listen to the podcast: here

Categories
Uncategorized

Dr. Mathias Flume – AMNOG will change in 2022, but how?

Dive into the heart of Germany’s healthcare landscape in this podcast episode, where Dr. Stefan Walzer engages in a riveting discussion with Dr. Mathias Flume, a core stakeholder within the regional payer system at one of the most innovative Statutory Health Insurance Physician Associations (KV Westphalia-Lippe). This episode unravels the complexities of the AMNOG process and provides an insider’s look into the market access process in Germany. Join us as Mathias gives his perspective in evaluating a decade of AMNOG: has it been a journey of success or a path of challenges? Tune in to gain unparalleled insights into the dynamics that shape healthcare in Germany.

Listen to the podcast: here